Brendan Bioscience, LLC

Website Links

Description

Dr. Dorval has over 20 years experience in strategic management of research, manufacturing and regulatory affairs in the area of medical devices and diagnostics. Most recently, Dr. Dorval founded Brendan BioScience to capatalize on patents covering new immunoassay methods for analyte detection. Brendan BioScience is focused on contract manufacturing and development of novel immunoassays for allergy, infectious diseases and other analytes. Previously, Dr. Dorval held a number of management positions including: Chief Technology Officer, V.P. Business Development and was the Chairman of the Scientific Advisory Board and member of the BOD. In addition, Dr. Dorval served as an advisor to the World Health Organization committee on vaccines and diagnostics. Dr. Dorval has several patents covering rapid assays, novel biomarkers and a novel Polio Virus vaccine. He was instrumental in obtaining funding for these projects through Venture Capital, NIH and WHO. Dr. Dorval holds a Ph.D. in Medical Microbiology and Immunology from the College of Medicine, The Ohio State University and performed postdoctoral studies and was a Visiting Scholar in the Department of Chemistry at the Massachusetts Institute of Technology.

Products & services

Similar companies nearby